Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00234585 · ClinicalTrials.gov registry record · Phase 2
Prospective Randomized Study Comparing Renal Artery Stenting (RESIST)With/Without Distal Protection
A Phase 2 study, sponsored by University of Toledo Health Science Campus.
- Completed
- Registry status
- Phase 2
- Development phase
- 100
- Enrollment target
NCT00234585 is a Phase 2 study that has completed, run by University of Toledo Health Science Campus. The registered enrollment target is 100 participants.
The verdict
NCT00234585, a Phase 2 study, has completed, sponsored by University of Toledo Health Science Campus.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 100 participants
- Enrollment target
Study Summary
This study is designed to demonstrate the safety and efficacy of using a protective device/drug to prevent renal injury during renal artery stenting and to assess whether the preventative effects are measurable and if there is a differential treatment effect for either device alone or in combination.
Interventions
- DEVICE Renal Artery Stent with Protective Device/Drug
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2002-08 |
| Est. Completion | 2007-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00234585
The ClinicalTrials.gov registry entry for NCT00234585 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Toledo Health Science Campus, which has 26 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Renal Artery Stent with Protective Device/Drug is the first listed.
NCT00234585 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00234585 about?
NCT00234585 is a clinical study titled "Prospective Randomized Study Comparing Renal Artery Stenting (RESIST)With/Without Distal Protection". This study is designed to demonstrate the safety and efficacy of using a protective device/drug to prevent renal injury during renal artery stenting and to assess whether the preventative effects are measurable and if there is a differential treatment effect for either device alone or in combination...
What is the current status of trial NCT00234585?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 100 participants. The study started on 2002-08. Estimated completion is 2007-06.
What interventions are being tested in trial NCT00234585?
The interventions under investigation include: Renal Artery Stent with Protective Device/Drug (DEVICE).
Who is sponsoring clinical trial NCT00234585?
This trial is sponsored by University of Toledo Health Science Campus, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.